New product [Regulatives / Guidelines]

posted by Ohlbe – France, 2020-03-11 18:54 (1528 d 13:11 ago) – Posting: # 21257
Views: 4,345

Dear SKM,

❝ Both the APIs are registered and marketed as separate formulation. We are mixing these two at same ratio into one formulation without adding any new excipients. I don't know why will it be considered as a new product. Can you guide me please?

Well, you are giving all the arguments yourself: up to now the two active substances are only marketed as separate formulations. You will be mixing them into one new formulation, which has never been tested or marketed before. Sorry, but I can't explain more.


Complete thread:

UA Flag
 Admin contact
23,029 posts in 4,834 threads, 1,641 registered users;
32 visitors (0 registered, 32 guests [including 10 identified bots]).
Forum time: 09:05 CEST (Europe/Vienna)

The most erroneous stories are those we think we know best–
and therefore never scrutinize or question.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz